Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ten year audit of secondary prevention in coronary bypass patients.

× No keyword cloud information.

5 in total

1. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators.

Authors: J B Cavender; W J Rogers; L D Fisher; B J Gersh; C J Coggin; W O Myers
Journal: J Am Coll Cardiol Date: 1992-08 Impact factor: 24.094

2. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

Authors: T J Bowker; T C Clayton; J Ingham; N R McLennan; H L Hobson; S D Pyke; B Schofield; D A Wood
Journal: Heart Date: 1996-04 Impact factor: 5.994

3. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

Authors:
Journal: N Engl J Med Date: 1997-01-16 Impact factor: 91.245

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors:
Journal: Lancet Date: 1994-11-19 Impact factor: 79.321

5 in total

4 in total

4. The provision of secondary cardiac prevention measures in a hospital cardiac clinic population and the relationship to psychological variables.

Authors: M Lynch; A W Murphy; J Walsh; K Daly; M Hynes
Journal: Ir J Med Sci Date: 2002 Jan-Mar Impact factor: 1.568

4 in total

Ten year audit of secondary prevention in coronary bypass patients.

1. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators.

2. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

3. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1. Long standing heart disease should be better screened.

2. Undertreatment of hypercholesterolaemia: a population-based study.

3. Improving secondary prevention in coronary bypass patients: closing the audit loop.

4. The provision of secondary cardiac prevention measures in a hospital cardiac clinic population and the relationship to psychological variables.